Francisco Javier Ampudia‐Blasco

Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009–2014

Cintia Muñoz-Quiles, Mónica López‐Lacort, Francisco Javier Ampudia‐Blasco et al. · Human Vaccines & Immunotherapeutics · 2017 · 70 citations · Full text

Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience

Ana Palanca, Falco van Nes, Felipe Pardo et al. · Diabetes Care · 2022 · 55 citations · Full text

Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target

Paolo Rossetti, Carmen Quirós, Vanessa Moscardó et al. · Diabetes Technology & Therapeutics · 2017 · 52 citations · Full text

Reimbursement for Continuous Glucose Monitoring: A European View

Lutz Heinemann, Sylvia Franc, Moshe Phillip et al. · Journal of Diabetes Science and Technology · 2012 · 48 citations · Full text

Diabetes Management, Real-time Cgm, Health Policy +10

Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

Ana Palanca, Francisco Javier Ampudia‐Blasco, José Miguel Calderón et al. · Diabetes Therapy · 2023 · 37 citations · Full text